AX
AXPH.EGX Alexandria Pharmaceuticals
1,392 EGP
Close of Oct 29, 2026
775.60
1,705
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is AXPH.EGX undervalued?
Graham numberThe Graham number of Alexandria Pharmaceuticals cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Alexandria Pharmaceuticals fundamental analysis
No fundamental analysis for Alexandria Pharmaceuticals yet.
Alexandria Pharmaceuticals stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Financial statements of Alexandria Pharmaceuticals are not available yet.
Alexandria Pharmaceuticals dividends
Alexandria Pharmaceuticals has not paid dividends in the last 1 fiscal years.
Who owns Alexandria Pharmaceuticals
Ownership data of Alexandria Pharmaceuticals is not available yet.
Alexandria Pharmaceuticals company profile
- Company name
- Alexandria Pharmaceuticals
- Ticker
- AXPH.EGX
- ISIN
- EGS38341C011
- Exchange
- Egyptian Exchange
- Sector
- -
- Industry
- -
- Address
- Website
- -